ROIV
#519
Roivant Sciences Ltd. - Common Shares
34.5 9 USD
-0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.92%
Changement Mensuel
+15.18%
Evolution sur 6 mois
+51.38%
Changement Annuel
+88.91%
Clôture Précédente
34.9 1
Open
34.7 4
Low
34.3 4
High
34.7 7
Volume
300
Financials
- Market Capitalization 24.88 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry Biotechnologies
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 387 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 280.55 USD | -0.25% | -12.05% | -2.63% | -9.86% | 37.46 B USD | ||
| 492 |  MRNA Moderna, Inc. - Common Stock | 67.07 USD | -0.55% | -9.16% | +28.88% | +111.44% | 26.61 B USD | ||
| 523 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 55.40 USD | -0.49% | -4.32% | +2.06% | +48.68% | 24.63 B USD | ||
| 538 |  INSM Insmed Incorporated - Common Stock | 109.12 USD | -0.90% | -4.62% | +11.92% | -32.66% | 23.65 B USD |